EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy of injectable platelet‐rich fibrin in the treatment of symptomatic oral lichen planus

Noor Al-Hallak, Omar Hamadah iD, Manal Mouhamad, Omar Kujan iD

Oral Diseases · 2023-07 · 29 (5) · 2256-2264

DOI: 10.1111/odi.14261 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Oral Diseases, online erschienen am 30.05.2022. Verfasst von Noor Al-Hallak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, The Faculty of Dental Medicine, Damascus University, Damascus, Syria. Hauptthemen laut MEDLINE: Lichen Planus, Oral, Platelet-Rich Fibrin. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The use of autologous platelet concentrates has shown growing evidence as a promising therapy. We conducted a split‐mouth study to evaluate the effectiveness of injectable platelet‐rich fibrin (PRF) compared with triamcinolone acetonide (TA) in the treatment of oral lichen planus (OLP). Materials and methods This split‐mouth randomized trial included 12 patients with symptomatic, bilateral OLP lesions. The participants were randomly allocated to receive a 1‐ml intralesional PRF injection on one side of the buccal mucosa and a 0.5‐ml TA injection on the counterpart side. The application was performed once a week for 4 weeks. The outcomes were measured using a visual analog scale score, REU score, and lesion areas.

Results

Both injectable TA and PRF were effective in the management of oral lichen planus. After 4 weeks of treatment, there was an average reduction in the VAS score (68.5% i‐PRF, 91% TA) and an average reduction in the REU score (74% i‐PRF, 91% TA). There were no statistically significant differences between the two treatment methods ( p > 0.05).

Conclusions

Intralesional injection with TA showed more effectiveness than i‐PRF in the management of OPL lesions. Although, i‐PRF cannot be considered a first‐line treatment option, it showed promising alternative therapy choice with no side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lichen Planus, OralPlatelet-Rich FibrinHumansTriamcinolone AcetonideGlucocorticoidsAdministration, Topical

Stichwörter der Autor:innen

intralesional injectionlichen planusplatelet-rich fibrintriamcinolone acetonide

Substanzen

Triamcinolone AcetonideGlucocorticoids

Autor:innen und Institutionen

  • Department of Oral Medicine, The Faculty of Dental Medicine, Damascus University, Damascus, Syria.
  • Department of Oral Medicine and Pathology, The Faculty of Dental Medicine, AL-Sham Privat University, Damascus, Syria.
  • Department of Dermatology, The Faculty of Medicine, Damascus University, Damascus, Syria.
  • Oral Diagnostic and Surgical Sciences, UWA Dental School, The University of Western Australia, Perth, WA, Australia.

ORCID-Profile: Omar Hamadah, Omar Kujan

Zitieren

APA

Al-Hallak, N., Hamadah, O., Mouhamad, M., & Kujan, O. (2023). Efficacy of injectable platelet‐rich fibrin in the treatment of symptomatic oral lichen planus. Oral Diseases, 29(5), 2256-2264. https://doi.org/10.1111/odi.14261

Vancouver

Al-Hallak N, Hamadah O, Mouhamad M, Kujan O. Efficacy of injectable platelet‐rich fibrin in the treatment of symptomatic oral lichen planus. Oral Diseases. 2023;29(5):2256-2264. doi:10.1111/odi.14261

BibTeX
@article{AlHallak2023,
  author = {Al-Hallak, Noor and Hamadah, Omar and Mouhamad, Manal and Kujan, Omar},
  title = {Efficacy of injectable platelet‐rich fibrin in the treatment of symptomatic oral lichen planus},
  journal = {Oral Diseases},
  year = {2023},
  volume = {29},
  number = {5},
  pages = {2256--2264},
  doi = {10.1111/odi.14261}
}
Kostenlos starten →